Lv2
200 积分 2022-06-06 加入
SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
1个月前
已完结
Alopecia areata investigational assessment guidelines*
1个月前
已完结
Two Phase 3 Trials of Baricitinib for Alopecia Areata
1个月前
已完结
Alopecia areata investigational assessment guidelines–Part II
1个月前
已完结
A Phase 3 Trial of Brepocitinib in Dermatomyositis
1个月前
已完结
Real-world Outcomes and Tolerability of JAK Inhibitors in Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Single-center Retrospective Study
6个月前
已关闭
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
8个月前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
9个月前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
9个月前
已完结
Psychometric Properties and Meaningful Change Thresholds of the Vitiligo Area Scoring Index
10个月前
已完结
皖公网安备34019202002308
